Falcon Physician ReviewsValueMD Sponsor
Home Forum Books Links Album Residency USMLE PreMed


Caribbean Medical Schools European Medical Schools Foreign Medical Schools Medical Resources
Go Back   ValueMD Medical Schools Forum > USMLE FORUMS > USMLE STEP 1 > Biochemistry And Genetics

Reply
 
LinkBack Thread Tools Display Modes
  #1 (permalink)  
Old 12-04-2004, 09:21 PM
Member
 
Join Date: Nov 2004
Posts: 112
increased LDL without elevation of other lipids

A patient with familial hypercholesterolemia undergoes a detailed serum lipid and lipoprotein analysis. Studies demonstrate elevated cholesterol in the form of increased LDL without elevation of other lipids. This patient's hyperlipidemia is best classified as which of the following types?

A. Type 1
B. Type 2a
C. Type 2b
D. Type 3
E. Type 5
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
  #2 (permalink)  
Old 12-05-2004, 07:23 PM
Asclepius1's Avatar
Newbie
 
Join Date: Feb 2006
Posts: 125
B.
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
  #3 (permalink)  
Old 12-06-2004, 10:09 PM
Member
 
Join Date: Nov 2004
Posts: 112
Re: increased LDL without elevation of other lipids

Quote:
Originally Posted by BioPatel
A patient with familial hypercholesterolemia undergoes a detailed serum lipid and lipoprotein analysis. Studies demonstrate elevated cholesterol in the form of increased LDL without elevation of other lipids. This patient's hyperlipidemia is best classified as which of the following types?

A. Type 1
B. Type 2a
C. Type 2b
D. Type 3
E. Type 5
The correct answer is B. Hyperlipidemia has been subclassified based on the lipid and lipoprotein profiles. Type 2a, which this patient has, can be seen in a hereditary form, known as familial hypercholesterolemia, and also in secondary, acquired forms related to nephritic syndrome and hyperthyroidism. The root problem appears to be a deficiency of LDL receptors, which leads to a specific elevation of cholesterol in the form of increased LDL. Heterozygotes for the hereditary form generally develop cardiovascular disease from 30 to 50 years of age. Homozygotes may have cardiovascular disease in childhood.
Type 1 (choice A) is characterized by isolated elevation of chylomicrons.

Type 2b (choice C) is characterized by elevations of both cholesterol and triglycerides in the form of LDL and VLDL.

Type 3 (choice D) is characterized by elevations of triglycerides and cholesterol in the form of chylomicron remnants and IDL.

Type 5 (choice E) is characterized by elevations of triglycerides and cholesterol in the form of VLDL and chylomicrons.
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On
Forum Jump


All times are GMT -4. The time now is 12:04 PM.


Powered by vBulletin® Version 3.7.2
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
Search Engine Optimization by vBSEO 3.2.0 ©2008, Crawlability, Inc.
Copyright © 2003-2008 ValueMD, LLC. All rights reserved.
Home About Privacy Contact us Disclaimer Site Map Advertise

Site Meter

International Foreign and Caribbean medical schools,
ValueMD provides information on medical education from premed to residency